Four months into the COVID-19 pandemic and answers to questions about masks, vaccines and catching the virus are still evolving. We check in with Dr. Lynora Saxinger and Dr. Raywat Deonandan for the latest insights. »»» Subscribe to The National…
Justine is one of the hundreds of volunteers who have put themselves forward for Imperial’s COVID-19 vaccine trial at their West London study facility. The multi-billion pound study first tested 15 participants, with no concerns, and is now widening to…
NBC News’ Erika Edwards shares the stories of coronavirus patients who thought they had recovered from the coronavirus but are testing positive again just weeks later, raising questions about how long COVID-19 antibodies last. » Subscribe to NBC News: »…
Researchers say the first Covid-19 vaccine tested in the U.S. improved patients’ immune systems as they had hoped, and now the trial run will move on to mass testing. We asked Dr. Kohli to weigh in on this and more…
The RNA vaccine developed by Moderna now has published data in the New England Journal of Medicine and will be proceeding to the next phase of trials. Dr. Seheult of also discusses compelling hypotheses about the role of von Willebrand…
U.S. researchers reported on Tuesday, July 14, that Moderna’s COVID-19 vaccine candidate showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study. Subscribe to our official YouTube channel, Be the first to…
